{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:50:15Z","timestamp":1791640215879,"version":"4.3.4"},"reference-count":142,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"vor","delay-in-days":368,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neuron.2015.03.042","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T15:49:11Z","timestamp":1433346551000},"page":"1119-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":298,"title":["The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders"],"prefix":"10.1016","volume":"86","author":[{"given":"Sien","family":"Braat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.\u00a0Frank","family":"Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2015.03.042_bib1","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1012104107","article-title":"Correction of respiratory disorders in a mouse model of Rett syndrome","volume":"107","author":"Abdala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2015.03.042_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1755-5949.2007.00034.x","article-title":"GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2\/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer","volume":"14","author":"Atack","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuron.2015.03.042_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","article-title":"Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)","volume":"368","author":"Baird","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neuron.2015.03.042_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABA(A) alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuron.2015.03.042_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng0501-46","article-title":"First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the \u03b32-subunit gene","volume":"28","author":"Baulac","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib9","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib11","doi-asserted-by":"crossref","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","article-title":"Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial","volume":"4","author":"Berry-Kravis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2015.03.042_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/exnr.1999.7030","article-title":"Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome","volume":"156","author":"Blue","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2015.03.042_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/pr.54.2.247","article-title":"International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function","volume":"54","author":"Bowery","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2015.03.042_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.drudis.2014.01.013","article-title":"Fragile X syndrome neurobiology translates into rational therapy","volume":"19","author":"Braat","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuron.2015.03.042_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2014.06.028","article-title":"Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials","volume":"88","author":"Braat","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2015.03.042_bib16","article-title":"The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome","volume":"0","author":"Braat","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuron.2015.03.042_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/ebm.2010.010261","article-title":"Experimental models of Rett syndrome based on Mecp2 dysfunction","volume":"236","author":"Calfa","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.neuron.2015.03.042_bib18","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2015.03.042_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2015.03.042_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0000000000000291","article-title":"GABRA1 and STXBP1: novel genetic causes of Dravet syndrome","volume":"82","author":"Carvill","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2015.03.042_bib21","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1523\/JNEUROSCI.3287-12.2012","article-title":"Treatment of neurodevelopmental disorders in adulthood","volume":"32","author":"Castr\u00e9n","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fncel.2014.00245","article-title":"The contribution of inhibitory interneurons to circuit dysfunction in fragile X syndrome","volume":"8","author":"Cea-Del Rio","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2015.03.042_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nchembio.78","article-title":"Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila","volume":"4","author":"Chang","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuron.2015.03.042_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib26","doi-asserted-by":"crossref","first-page":"14646","DOI":"10.1073\/pnas.1211591109","article-title":"Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome","volume":"109","author":"Cheah","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2015.03.042_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2040-2392-5-36","article-title":"Genetic analysis of GABRB3 as a candidate gene of autism spectrum disorders","volume":"5","author":"Chen","year":"2014","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuron.2015.03.042_bib29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuron.2015.03.042_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib31","doi-asserted-by":"crossref","first-page":"E904","DOI":"10.1002\/humu.21083","article-title":"The SCN1A variant database: a novel research and diagnostic tool","volume":"30","author":"Claes","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuron.2015.03.042_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ng.3092","article-title":"Refining analyses of copy number variation identifies specific genes associated with developmental delay","volume":"46","author":"Coe","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib34","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.284.5420.1670","article-title":"Genetics of mouse behavior: interactions with laboratory environment","volume":"284","author":"Crabbe","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuron.2015.03.042_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2015.03.042_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABAA receptor: a novel target for treatment of fragile X?","volume":"30","author":"D\u2019Hulst","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib37","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D\u2019Hulst","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuron.2015.03.042_bib38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2015.03.042_bib40","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2015.03.042_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature13772","article-title":"Synaptic, transcriptional and chromatin genes disrupted in autism","volume":"515","author":"De Rubeis","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/hmg\/ddh146","article-title":"GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies","volume":"13","author":"Dibbens","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib43","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/ajmg.a.36761","article-title":"3p25.3 microdeletion of GABA transporters SLC6A1 and SLC6A11 results in intellectual disability, epilepsy and stereotypic behavior","volume":"164A","author":"Dikow","year":"2014","journal-title":"Am. J. Med. Genet. A."},{"issue":"Suppl\u00a02","key":"10.1016\/j.neuron.2015.03.042_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib45","doi-asserted-by":"crossref","first-page":"e68851","DOI":"10.1371\/journal.pone.0068851","article-title":"Abnormal expression of cerebrospinal fluid cation chloride cotransporters in patients with Rett syndrome","volume":"8","author":"Duarte","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2015.03.042_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2012.08.012","article-title":"Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility","volume":"49","author":"Dutton","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2015.03.042_bib47","doi-asserted-by":"crossref","first-page":"e92169","DOI":"10.1371\/journal.pone.0092169","article-title":"GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice","volume":"9","author":"El-Khoury","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2015.03.042_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","article-title":"De novo mutations in the classic epileptic encephalopathies","volume":"501","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2015.03.042_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib51","article-title":"GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism","author":"Fatemi","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuron.2015.03.042_bib52","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s10803-014-2078-x","article-title":"Downregulation of GABAA receptor protein subunits \u03b16, \u03b22, \u03b4, \u03b5, \u03b32, \u03b8, and \u03c12 in superior frontal cortex of subjects with autism","volume":"44","author":"Fatemi","year":"2014","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuron.2015.03.042_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","article-title":"The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator","volume":"56","author":"Fisher","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2015.03.042_bib54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00424-003-1091-2","article-title":"The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids","volume":"447","author":"Gasnier","year":"2004","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuron.2015.03.042_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrn3249","article-title":"Regulation of neuronal GABA(B) receptor functions by subunit composition","volume":"13","author":"Gassmann","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature13394","article-title":"Genome sequencing identifies major causes of severe intellectual disability","volume":"511","author":"Gilissen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib57","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neuron.2011.05.021","article-title":"Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses","volume":"70","author":"Gilman","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2015.03.042_bib58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuron.2007.11.002","article-title":"Activation of GABAA receptors: views from outside the synaptic cleft","volume":"56","author":"Glykys","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2015.03.042_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature09764","article-title":"Charting a course for genomic medicine from base pairs to bedside","volume":"470","author":"Green","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2012.11.002","article-title":"Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus","volume":"67","author":"Grosenbaugh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2015.03.042_bib61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib62","series-title":"Fragile X Syndrome: Diagnosis, Treatment and Research","first-page":"3","article-title":"Physical and behavioral phenotype","author":"Hagerman","year":"2002"},{"key":"10.1016\/j.neuron.2015.03.042_bib63","article-title":"Tourette syndrome: update","author":"Hallett","year":"2015","journal-title":"Brain Dev. Published online January 17, 2015"},{"key":"10.1016\/j.neuron.2015.03.042_bib64","doi-asserted-by":"crossref","first-page":"e1004772","DOI":"10.1371\/journal.pgen.1004772","article-title":"De novo mutations in moderate or severe intellectual disability","volume":"10","author":"Hamdan","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature11356","article-title":"Autistic-like behaviour in Scn1a+\/- mice and rescue by enhanced GABA-mediated neurotransmission","volume":"489","author":"Han","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1352\/2008.113:427-438","article-title":"Autism profiles of males with fragile X syndrome","volume":"113","author":"Harris","year":"2008","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.neuron.2015.03.042_bib67","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1523\/JNEUROSCI.4447-13.2014","article-title":"The developmental switch in GABA polarity is delayed in fragile X mice","volume":"34","author":"He","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib68","doi-asserted-by":"crossref","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABA(B) receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2015.03.042_bib69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2012.01.031","article-title":"Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model","volume":"229","author":"Heulens","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2015.03.042_bib70","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/npp.2014.92","article-title":"Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder","volume":"39","author":"Hodges","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2015.03.042_bib71","doi-asserted-by":"crossref","first-page":"1255263","DOI":"10.1126\/science.1255263","article-title":"Interneurons. Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuron.2015.03.042_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature13908","article-title":"The contribution of de novo coding mutations to autism spectrum disorder","volume":"515","author":"Iossifov","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib73","doi-asserted-by":"crossref","first-page":"C844","DOI":"10.1152\/ajpcell.00399.2012","article-title":"GABAergic synaptic inputs of locus coeruleus neurons in wild-type and Mecp2-null mice","volume":"304","author":"Jin","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuron.2015.03.042_bib74","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1523\/JNEUROSCI.2162-07.2007","article-title":"Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy","volume":"27","author":"Kalume","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib75","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neuron.2015.03.042_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.a.30229","article-title":"Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors","volume":"129A","author":"Kaufmann","year":"2004","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.neuron.2015.03.042_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(00)00170-4","article-title":"Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial","volume":"42","author":"Kerrigan","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuron.2015.03.042_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","article-title":"A de novo convergence of autism genetics and molecular neuroscience","volume":"37","author":"Krumm","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib79","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1528-1157.2000.tb00324.x","article-title":"Assessment of ganaxolone\u2019s anticonvulsant activity using a randomized, double-blind, presurgical trial design","volume":"41","author":"Laxer","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib80","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl. Psychiatr."},{"key":"10.1016\/j.neuron.2015.03.042_bib81","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2788.2006.00803.x","article-title":"Cognitive, language and social-cognitive skills of individuals with fragile X syndrome with and without autism","volume":"50","author":"Lewis","year":"2006","journal-title":"J.\u00a0Intellect. Disabil. Res."},{"key":"10.1016\/j.neuron.2015.03.042_bib82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2011.04.060","article-title":"Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation","volume":"21","author":"Li","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuron.2015.03.042_bib83","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/npp.2013.291","article-title":"Association of gamma-aminobutyric acid A receptor \u03b12 gene (GABRA2) with alcohol use disorder","volume":"39","author":"Li","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2015.03.042_bib84","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.braindev.2008.07.011","article-title":"A catalog of SCN1A variants","volume":"31","author":"Lossin","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuron.2015.03.042_bib85","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroimage.2003.10.050","article-title":"GABA A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil","volume":"22","author":"Lucignani","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuron.2015.03.042_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2377-4-20","article-title":"Homozygosity for a missense mutation in the 67\u00a0kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders","volume":"4","author":"Lynex","year":"2004","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuron.2015.03.042_bib87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/433195","article-title":"Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism","volume":"77","author":"Ma","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib88","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pharmthera.2009.11.007","article-title":"Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs","volume":"125","author":"Madsen","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2015.03.042_bib89","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.20874","article-title":"A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy","volume":"59","author":"Maljevic","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2015.03.042_bib90","first-page":"355","article-title":"Paradoxical reactions elicited by diazepam in children with classic autism","volume":"2","author":"Marrosu","year":"1987","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neuron.2015.03.042_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib92","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib93","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1023\/A:1005500122231","article-title":"4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency","volume":"22","author":"Medina-Kauwe","year":"1999","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.neuron.2015.03.042_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome","volume":"99","author":"Medrihan","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuron.2015.03.042_bib95","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0896-6273(03)00034-5","article-title":"RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice","volume":"37","author":"Miyashiro","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2015.03.042_bib96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tins.2004.07.002","article-title":"Diversity of inhibitory neurotransmission through GABA(A) receptors","volume":"27","author":"Mody","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib97","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1528-1157.1997.tb01486.x","article-title":"Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity","volume":"38","author":"Monaghan","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib98","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1528-1157.1999.tb00824.x","article-title":"Epilepsy and EEG findings in males with fragile X syndrome","volume":"40","author":"Musumeci","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib99","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2015.03.042_bib100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuron.2015.03.042_bib101","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":"Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations","volume":"485","author":"O\u2019Roak","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.113.203331","article-title":"Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome","volume":"345","author":"Oakley","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2015.03.042_bib103","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000332884","article-title":"The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome","volume":"33","author":"Olmos-Serrano","year":"2011","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2015.03.042_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1","author":"Omrani","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2015.03.042_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000329420","article-title":"Fragile X syndrome: the GABAergic system and circuit dysfunction","volume":"33","author":"Paluszkiewicz","year":"2011","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib108","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","article-title":"Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency","volume":"73","author":"Pearl","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2015.03.042_bib109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Preclinical research: Make mouse studies work","volume":"507","author":"Perrin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0022-3476(88)80060-X","article-title":"Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome","volume":"112","author":"Perry","year":"1988","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuron.2015.03.042_bib111","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib112","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.eplepsyres.2014.07.001","article-title":"Association of GABRA6 1519 T>C (rs3219151) and Synapsin II (rs37733634) gene polymorphisms with the development of idiopathic generalized epilepsy","volume":"108","author":"Prasad","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuron.2015.03.042_bib113","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/embr.201438749","article-title":"A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation","volume":"15","author":"Puskarjov","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuron.2015.03.042_bib114","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1167.2006.00497.x","article-title":"Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels","volume":"47","author":"Quilichini","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuron.2015.03.042_bib115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molmed.2011.03.003","article-title":"The contribution of GABAergic dysfunction to neurodevelopmental disorders","volume":"17","author":"Ramamoorthi","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuron.2015.03.042_bib116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31825dcf71","article-title":"GABAB-ergic motor cortex dysfunction in SSADH deficiency","volume":"79","author":"Reis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2015.03.042_bib117","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuron.2015.03.042_bib118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuron.2015.03.042_bib119","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2015.03.042_bib120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuron.2015.03.042_bib121","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib122","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuron.2015.03.042_bib123","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng0696-183","article-title":"Bartter\u2019s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2","volume":"13","author":"Simon","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib124","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/ajmg.a.36714","article-title":"A novel variant in GABRB2 associated with intellectual disability and epilepsy","volume":"164A","author":"Srivastava","year":"2014","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.neuron.2015.03.042_bib125","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1093\/hmg\/ddu272","article-title":"Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences","volume":"23","author":"Suhl","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib126","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ajhg.2008.04.020","article-title":"Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy","volume":"82","author":"Tanaka","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib127","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jnc.12803","article-title":"Developmental abnormalities of cortical interneurons precede symptoms onset in a mouse model of Rett syndrome","volume":"131","author":"Tomassy","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2015.03.042_bib128","doi-asserted-by":"crossref","first-page":"e62322","DOI":"10.1371\/journal.pone.0062322","article-title":"Social cognitive role of schizophrenia candidate gene GABRB2","volume":"8","author":"Tsang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuron.2015.03.042_bib129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1073\/pnas.1417989112","article-title":"Giant ankyrin-G stabilizes somatodendritic GABAergic synapses through opposing endocytosis of GABAA receptors","volume":"112","author":"Tseng","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2015.03.042_bib130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuron.2015.03.042_bib131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-genet-110410-132512","article-title":"Genetic and epigenetic networks in intellectual disabilities","volume":"45","author":"van Bokhoven","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib132","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2015.03.042_bib133","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/aws368","article-title":"GABA deficit in the visual cortex of patients with neurofibromatosis type 1: genotype-phenotype correlations and functional impact","volume":"136","author":"Violante","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2015.03.042_bib134","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10110","article-title":"Transcriptomic analysis of autistic brain reveals convergent molecular pathology","volume":"474","author":"Voineagu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2015.03.042_bib135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.resp.2011.02.002","article-title":"The benzodiazepine Midazolam mitigates the breathing defects of Mecp2-deficient mice","volume":"177","author":"Voituron","year":"2011","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.neuron.2015.03.042_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol\u2014a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuron.2015.03.042_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0501-49","article-title":"Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures","volume":"28","author":"Wallace","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2015.03.042_bib138","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2040-2392-4-48","article-title":"Genetic variation in GABRB3 is associated with Asperger syndrome and multiple endophenotypes relevant to autism","volume":"4","author":"Warrier","year":"2013","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuron.2015.03.042_bib139","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-510X(97)00223-2","article-title":"Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome","volume":"154","author":"Yamashita","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuron.2015.03.042_bib140","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2015.03.042_bib141","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hipo.20389","article-title":"The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability","volume":"18","author":"Zhang","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuron.2015.03.042_bib142","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1152\/jn.00601.2009","article-title":"MeCP2 is required for normal development of GABAergic circuits in the thalamus","volume":"103","author":"Zhang","year":"2010","journal-title":"J.\u00a0Neurophysiol."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627315002664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627315002664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:26:21Z","timestamp":1748420781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627315002664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0896627315002664"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2015.03.042","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2015.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}